IP Library Granted Patent US 9,993,426
Granted Patent B2
US 9,993,426 · App. 15/258,865 · Granted Jun 12, 2018

Bisacodyl compositions and delivery apparatus

Inventors: Nelson P. Ayala (Lynchburg, VA); Ping Qiu (Roanoke, VA); Debanjan Das (Lynchburg, VA); Dave Zimmerman (Rustburg, VA)
Assignee: C. B. Fleet Company, Inc.
A61K9/08A61K9/0031A61K9/02A61K31/4402A61K47/10A61K47/32A61M3/0262A61M3/0279B32B1/08B32B15/08B32B15/085B32B15/20B32B27/08B32B27/32B65D35/14B65D35/24B65D47/12B32B2439/00B32B2439/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,993,426
App. No.
15/258,865
Granted
Jun 12, 2018
Kind
B2
Abstract

A pharmaceutical composition comprising bisacodyl [4,4′-(pyridine-2-ylmethylene)bis(4,1-phenylene) diacetate], a solvent, a buffer, and a polymer, methods and apparatus for delivery to a patient.

Claims (58)

1. An enema, comprising:

bisacodyl,

acrylates/C10-30 alkyl acrylate cross-polymer,

optionally, a solvent,

optionally, a pH adjuster,

optionally, a buffer,

optionally, a preservative,

optionally, a chelating agent, and

optionally, a wetting agent,

wherein the bisacodyl is present in an amount of at least 0.1% by weight, and

the enema is packaged in a laminate metal tube.

2. The enema of claim 1 , consisting essentially of:

bisacodyl,

acrylates/C10-30 alkyl acrylate cross-polymer,

optionally, a solvent,

optionally, a pH adjuster,

optionally, a buffer,

optionally, a preservative,

optionally, a chelating agent, and

optionally, a wetting agent.

3. The enema of claim 1 , wherein the bisacodyl is present in an amount of 0.1-0.5% by weight.

4. The enema of claim 1 , wherein the acrylates/C10-30 alkyl acrylate cross-polymer is present in an amount of 0.11-0.15% by weight.

5. The enema of claim 1 , further comprising the solvent,

wherein the solvent is present in an amount of 95-99% by weight, and

the solvent comprises at least one member selected from the group consisting of water and glycerin.

6. The enema of claim 1 , further comprising the pH adjuster,

wherein the pH adjuster is present in an amount of 0.02-0.05% by weight.

7. The enema of claim 1 , further comprising the buffer,

wherein the buffer is present in an amount of 0.01-0.04% by weight.

8. The enema of claim 1 , further comprising the preservative,

wherein the preservative is present in an amount of 0.01-0.4% by weight, and

the preservative comprises at least one member selected from the group consisting of methyl paraben and propyl paraben.

9. The enema of claim 1 , further comprising the chelating agent,

wherein the chelating agent is present in an amount of 0.02-0.08% by weight.

10. The enema of claim 1 , further comprising the wetting agent,

wherein the wetting agent is present in an amount of 0.002-0.010% by weight, and

the wetting agent comprises at least one member selected from the group consisting of octoxynol 9, polysorbate 20, polysorbate 60, polysorbate 80 and PEG 40 hydrogenated castor oil.

11. The enema of claim 1 , wherein the enema is formulated as a suspension.

12. The enema of claim 1 , wherein the enema has a pH of 5.0-6.8.

13. The enema of claim 1 , wherein the bisacodyl comprises bisacodyl particles having an average particle size of 5-15 μm.

14. The enema of claim 1 , wherein the bisacodyl is present in an amount of 0.1-0.5% by weight,

the acrylates/C10-30 alkyl acrylate cross-polymer is present in an amount of 0.11-0.15% by weight,

the solvent comprises water and glycerin in an amount of 95-99% by weight,

the preservative comprises methyl paraben and propyl paraben in an amount of 0.01-0.4% by weight,

the chelating agent comprises EDTA in an amount of 0.02-0.08% by weight, and

the wetting agent comprises octoxynol 9 in an amount of 0.002-0.010% by weight.

15. The enema of claim 2 , wherein the bisacodyl is present in an amount of 0.1-0.5% by weight,

the acrylates/C10-30 alkyl acrylate cross-polymer is present in an amount of 0.11-0.15% by weight,

the solvent comprises water and glycerin in an amount of 95-99% by weight,

the preservative comprises methyl paraben and propyl paraben in an amount of 0.01-0.4% by weight,

the chelating agent comprises EDTA in an amount of 0.02-0.08% by weight, and

the wetting agent comprises octoxynol 9 in an amount of 0.002-0.010% by weight.

16. The enema of claim 1 , wherein the bisacodyl is present in an amount of at least 0.30% by weight.

17. The enema of claim 1 , wherein the enema has a shelf life greater than 18 months.

18. The enema of claim 1 , wherein the enema has a shelf life greater than 24 months.

19. The enema of claim 1 , wherein the laminate metal tube is capable of holding 3-8 mL of enema.

20. The enema of claim 1 , wherein the laminate metal tube comprises a nozzle, and

a protective sheath, on the nozzle.

Assignments (4)
RELEASE OF TERM SECURITY INTERESTS Recorded Mar 18, 2025
From: BARCLAYS BANK PLC
To: BLACKSMITH BRANDS, INC.; C. B. FLEET COMPANY, INCORPORATED; DENTEK ORAL CARE, INC.; MEDTECH PRODUCTS INC.
Reel/Frame 070542/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2017
From: AYALA, NELSON P.; QIU, PING; DAS, DEBANJAN; ZIMMERMAN, DAVE
To: C.B. FLEET COMPANY, INC.
Reel/Frame 043433/0892 →
ABL SECURITY AGREEMENT Recorded Jan 31, 2017
From: C.B. FLEET COMPANY INCORPORATED
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 041567/0099 →
TERM LOAN SECURITY AGREEMENT Recorded Jan 30, 2017
From: C.B. FLEET COMPANY INCORPORATED
To: BARCLAYS BANK PLC, AS ADMINISTRATIVE AGENT
Reel/Frame 041554/0309 →
Continuity (2)
Provisional Application 62218795 · Sep 15, 2015
Related Publication 20170079911A1 · Mar 23, 2017